iScience (Nov 2021)

STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway

  • Xiaopei Hao,
  • Yao Zhang,
  • Yiwei Lu,
  • Guoyong Han,
  • Dawei Rong,
  • Guoqiang Sun,
  • Guangshun Sun,
  • Weiwei Tang,
  • Jindao Wu,
  • Xuehao Wang

Journal volume & issue
Vol. 24, no. 11
p. 103223

Abstract

Read online

Summary: Serine/threonine kinase 39 (STK39) is overexpressed in various tumor tissues and plays an essential role in tumor progression. In this study, we investigated the clinical value, as well as the potential functions and mechanisms of STK39 in cholangiocarcinoma (CCA). The results showed that STK39 was overexpressed in CCA and negatively associated with the prognosis of patients with CCA. Functionally, STK39 knockdown suppressed cell proliferation, migration, and invasion, while STK39 overexpression facilitated tumor aggressiveness. The tumor-promoting effects of STK39 in CCA were also validated by in vivo experiments. Mechanistically, RNA-seq analysis identified that STK39 enhanced the progression of CCA by activating PI3K/AKT signaling pathway. Furthermore, overexpression of STK39 could induce gemcitabine resistance in CCA cells. Moreover, the increased expression of STK39 may be mediated by the dysregulation of miR-26a-5p. In summary, STK39 could be served as a valuable prognostic candidate and a potential therapeutic target of CCA.

Keywords